Merck Signs Definitive Deal to Acquire Mirus Bio for USD 600 Million
Merck has signed a definitive agreement to acquire Mirus Bio for USD 600 million.
Genetic Material | 27/05/2024 | By Aishwarya | 149
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy